1.0 Abstract
Background Postpartum cardiomyopathy (PPCM) is a condition that is characterized by the weakening of heart muscles which is known as left ventricular dysfunction and occurs during the later stages of pregnancy or during the early stages of postpartum.
Objective To evaluate the role of abnormal immune responses and risk factors such as advanced age, high parity, and presence of gestational diabetes in the pathogenesis of PPCM in Ethiopia.
Method A cross-sectional hospital-based study was conducted at Saint Paul Millennium Medical College (SPMCC) between January 2021 and January 2023. All female pregnant patients who were attending the Maternal Care Fetal Unit, Antenatal Unit, and High-Risk Unit at SPMMC were included in this study. However, among those patients, those mothers younger than 20 years old and older than 40 years old were excluded from the study. The total sample size collected from this facility was 250 patients.
Results Oxidative stress and inflammation were primarily correlated with pre-eclampsia and gestational diabetes. These risk factors were particularly prevalent within patients diagnosed with PPCM, 52.8% and 40% respectively. Prolactin Cleavage and Microvascular Dysfunction was associated with higher BMI and advanced age. With a general increasing trend observed in PPCM incidence and advancing age. As well as a high prevalence rate of PPCM in patients with Obesity Class I (at 33.0%). Another notable risk factor was high parity ( 45.0% with 4+ prior pregnancies). The most common symptom presented was dyspnea at 35.0%. The mortality rate was 14% whilst recurrence and the fully recovered ratio were at 13.1% and 34.0%, respectively.
Conclusion Results aligned with those conducted in other African countries (e.g. Zambia and South Africa) however mitigating high mortality as well as low full recovery rate will need to be done by earlier diagnosis, effective treatment, and intervention mechanisms. A different study design will need to be conducted (over a longer time period) to support and make findings more holistic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did no receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of the International Community School of Addis Ababa as well as Saint Paul Medical Millennium College gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
